Affordable Access

Anorectic and behavioural effects of bupropion.

Authors
  • Zarrindast, M R1
  • Hosseini-Nia, T
  • 1 Department of Pharmacology, Faculty of Medicine, University of Tehran, Iran. , (Iran)
Type
Published Article
Journal
General Pharmacology The Vascular System
Publisher
Elsevier
Publication Date
Jan 01, 1988
Volume
19
Issue
2
Pages
201–204
Identifiers
PMID: 3127269
Source
Medline
License
Unknown

Abstract

1. Bupropion (12.5-75 mg kg-1) was given intraperitoneally to rats and was found to decrease the food consumption of the animals dose-dependently. While phenoxybenzamine, propranolol and methergoline failed to antagonize the anorectic effect of the drug; pimozide a dopamine receptor blocker decreased anorexia induced by bupropion. 2. Bupropion (12.5-50 mg kg-1) also caused a marked increase in locomotor activity of the rats. The increase in locomotion produced by bupropion was completely antagonized by pretreatment of the animals with pimozide and reserpine plus a-methyl-p-tyrosine, but not by pretreatment with phenoxybenzamine, propranolol or methergoline. 3. Taking into considerations the evidences of dopaminergic properties of bupropion shown by the others, it could be suggested that the anorexia and hyperactivity produced by bupropion may be induced through the indirect dopaminergic mechanism.

Report this publication

Statistics

Seen <100 times